Core Points - Lands' End, Inc. will host a conference call on December 9, 2025, at 8:30 a.m. Eastern Time to discuss its third quarter 2025 financial results [1] - A news release with the financial results will be issued prior to the call [1] - An online archive of the conference call will be available on the company's website around noon on the same day [2] Company Overview - Lands' End, Inc. is a leading digital retailer specializing in solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms [3] - The company sells products through its website, third-party distribution channels, company-operated stores, and third-party license agreements [3] - Lands' End also provides products to businesses and schools through the Outfitters distribution channel, positioning itself as a classic American lifestyle brand [3]

SHANGHAI, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that it has called an extraordinary general meeting of shareholders (the “EGM”), to be held on December 31, 2025 at 10 a.m. (Beijing time) at 1102 Xiehe Road, Changning District, Shanghai, People’s Republic of China, to consider and vote on, among other matters, the proposal to authorize and approve the prev ...

Core Viewpoint - Wearable Devices Ltd. has entered into a warrant inducement agreement with an institutional investor for the immediate exercise of existing warrants, raising approximately $5.68 million for working capital and corporate purposes [1][3]. Group 1: Warrant Inducement Agreement - The company will allow the immediate exercise of existing warrants to purchase up to 3,322,000 ordinary shares at an exercise price of $1.71 per share [1]. - In exchange for the immediate exercise, the company will issue new unregistered warrants to the investor to purchase up to 5,813,500 ordinary shares at an exercise price of $1.86 per share [3]. - The closing of this transaction is expected around December 1, 2025, pending customary closing conditions [3]. Group 2: Financial Advisor and Regulatory Compliance - A.G.P./Alliance Global Partners is acting as the exclusive financial advisor for this warrant inducement transaction [2]. - The private placement of the new warrants will rely on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933 and Regulation D [4]. Group 3: Company Overview - Wearable Devices Ltd. is a pioneer in AI-powered wearable gesture control technology, focusing on human-computer interaction through its products like the Mudra Band and Mudra Link [6][8]. - The company operates a dual-channel model, offering direct-to-consumer sales and enterprise licensing, enhancing user experiences in gaming, productivity, and extended reality [7].

Core Insights - Profound Medical Corp. is launching the TULSA-AI Volume Reduction module for treating benign prostatic hyperplasia (BPH) at the RSNA meeting, enhancing the TULSA Procedure's versatility and potential for mainstream adoption [1][4] Company Overview - Profound Medical Corp. is a commercial-stage medical device company focused on AI-powered, MRI-guided, incision-free therapies for ablation of diseased tissue [9][10] - The TULSA Procedure™ is the only incision-free option for prostate cancer and BPH, utilizing real-time MRI guidance for precision [3][10] Product Details - The TULSA-AI Volume Reduction module allows for efficient stacking of multiple prostate cases in one day, improving workflow and reducing procedure times [3][4] - The TULSA Procedure has shown significantly reduced risks of sexual function loss and incontinence compared to traditional methods, with superior outcomes in blood loss, length of stay, post-operative pain, and recovery time [3][4] Market Potential - The launch of the TULSA-AI module is expected to triple Profound's total available market in prostate disease to approximately 600,000 patients annually [4] - The TULSA Procedure is positioned to become a mainstream treatment across various prostate disease conditions, including low-, intermediate-, and high-risk prostate cancer, as well as BPH [10] Event Participation - Profound Medical will showcase the TULSA-AI Volume Reduction module and present new clinical data at the RSNA and SUO meetings [5][6][7]

ALMATY, Kazakhstan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- On the 27th March 2025 Joint Stock Company Kaspi.kz (“Kaspi.kz” NASDAQ: KSPI) signed a share purchase agreement with Rabobank Group, relating to the purchase of Rabobank’s Turkish subsidiary Rabobank A.Ş. The closing of the transaction remains subject to the receipt of the required regulatory approvals and satisfaction of all customary closing conditions. We now expect this to take place in mid-2026. For further information David Ferguson david.ferguson@ ...

Renewal of NCIB Allows Continued Repurchase of Shares for CancellationUp to 11.7 Million Shares May be Purchased for CancellationPrimary NCIB Goal Remains Maintaining a Constant YOY Outstanding Share CountAmerigo’s Capital Return Strategy Includes Quarterly Dividends, Performance Dividends & NCIB VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce that it has received approval from the Toronto Stoc ...

VANCOUVER, British Columbia, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Leviathan Metals Corp. (“Leviathan” or the “Company”) (LVX – TSXV, LVXFF – OTC, 0GP – FSE) is pleased to announce closing of its previously announced transaction (the “Transaction”) with Cura Exploration Botswana Corp. (“Cura”). The Transaction was carried out by way of an amalgamation under the laws of the Province of British Columbia pursuant to the terms of an amalgamation agreement dated September 11, 2025 (as amended on October 31, 2025) be ...

RENO, Nev., Nov. 28, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, brings to market the Battle Born® Power Station Series, the company’s debut line of all-in-one portable power stations designed for demanding professional and off-grid applications. The Battle Born® Power Station 3000 and Battle Born® Power Station Pro 5000 expand the Company’s product portfolio into ful ...

Core Insights - TG Therapeutics, Inc. will participate in the 8th Annual Evercore Healthcare Conference from December 2-4, 2025, with a fireside chat scheduled for December 2, 2025, at 12:30 PM ET [1] Company Overview - TG Therapeutics is a fully integrated, commercial-stage biopharmaceutical company focused on developing and commercializing novel treatments for B-cell diseases [3] - The company has received FDA approval for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease [3] - BRIUMVI has also received approval from several regulatory agencies outside the U.S. for treating adult patients with relapsing multiple sclerosis who have active disease defined by clinical or imaging features [3]

WINNIPEG, Manitoba, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announced its third quarter 2025 financial results. Third Quarter 2025 Financial Highlights (Comparatives exclude discontinued STEM Animal Health “STEM” Operations): Total revenue for the three months ended September 30, 2025 was $8,499 compared to $1,282,698 in the three months ended September 30, 2024. The vast majority of revenue recorded in the comparative quarter was relat ...